Literature DB >> 30476296

Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence.

David Barros1, Francisco García-Río2,3,4.   

Abstract

Lipid metabolism deregulation constitutes the pathogenic basis for the development of atherosclerosis and justifies a high incidence of cardiovascular-related morbidity and mortality. Some data suggest that dyslipidemia may be associated with sleep-disordered breathing, mainly obstructive sleep apnea (OSA), due to alterations in fundamental biochemical processes, such as intermittent hypoxia (IH). The aim of this systematic review was to identify and critically evaluate the current evidence supporting the existence of a possible relationship between OSA and alterations in lipid metabolism. Much evidence shows that, during the fasting state, OSA and IH increase lipid delivery from the adipose tissue to the liver through an up-regulation of the sterol regulatory element-binding protein-1 and stearoyl-CoA desaturase-1, increasing the synthesis of cholesterol esters and triglycerides. In the postprandial state, lipoprotein clearance is delayed due to lower lipoprotein lipase activity, probably secondary to IH-up-regulation of angiopoietin-like protein 4 and decreased activity of the peroxisome proliferator-activated receptor alpha. Moreover, oxidative stress can generate dysfunctional oxidized lipids and reduce the capacity of high-density lipoproteins (HDL) to prevent low-density lipoprotein (LDL) oxidation. In the clinical field, several observational studies and a meta-regression analysis support the existence of a link between OSA and dyslipidemia. Although there is evidence of improved lipid profile after apnea-hypopnea suppression with continuous positive airway pressure (CPAP), the majority of the data come from observational studies. In contrast, randomized controlled trials evaluating the effects of CPAP on lipid metabolism present inconclusive results and two meta-analyses provide contradictory evidence. © Sleep Research Society 2018. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  fatty acids; intermittent hypoxia; lipids; oxidative stress; sleep apnea

Mesh:

Substances:

Year:  2019        PMID: 30476296     DOI: 10.1093/sleep/zsy236

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  21 in total

1.  Comparison of Composite Lipid Indices in Patients with Obstructive Sleep Apnoea.

Authors:  Andras Bikov; Stefan Frent; Daniela Reisz; Alina Negru; Laura Gaita; Daniel Breban Schwarzkopf; Stefan Mihaicuta
Journal:  Nat Sci Sleep       Date:  2022-07-27

2.  Obesity and Obstructive Sleep Apnea.

Authors:  Maria R Bonsignore
Journal:  Handb Exp Pharmacol       Date:  2022

Review 3.  The Mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction.

Authors:  Abdelnaby Khalyfa; David Sanz-Rubio
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

4.  The association of obstructive sleep apnea with dyslipidemia in Korean children and adolescents: a single-center, cross-sectional study.

Authors:  Eun Kyeong Kang; Min Jeong Jang; Ki Duk Kim; Young Min Ahn
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

5.  SMAD4 Overexpression in Patients with Sleep Apnoea May Be Associated with Cardiometabolic Comorbidities.

Authors:  Elena Díaz-García; Ana Jaureguizar; Raquel Casitas; Sara García-Tovar; Begoña Sánchez-Sánchez; Ester Zamarrón; Eduardo López-Collazo; Francisco García-Río; Carolina Cubillos-Zapata
Journal:  J Clin Med       Date:  2020-07-25       Impact factor: 4.241

Review 6.  Oxygenation of adipose tissue: A human perspective.

Authors:  Ioannis G Lempesis; Rens L J van Meijel; Konstantinos N Manolopoulos; Gijs H Goossens
Journal:  Acta Physiol (Oxf)       Date:  2019-06-02       Impact factor: 6.311

Review 7.  Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles.

Authors:  Abdelnaby Khalyfa; Anabel L Castro-Grattoni; David Gozal
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

8.  Atherogenic Index of Plasma in Obstructive Sleep Apnoea.

Authors:  Andras Bikov; Martina Meszaros; Laszlo Kunos; Alina Gabriela Negru; Stefan Marian Frent; Stefan Mihaicuta
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

9.  Cell-Selective Altered Cargo Properties of Extracellular Vesicles Following In Vitro Exposures to Intermittent Hypoxia.

Authors:  David Sanz-Rubio; Abdelnaby Khalyfa; Zhuanhong Qiao; Jorge Ullate; José M Marin; Leila Kheirandish-Gozal; David Gozal
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

10.  Markers of cardiovascular disease risk in sleep-disordered breathing with or without comorbidities: the Nagahama study.

Authors:  Yoshinari Nakatsuka; Kimihiko Murase; Takeshi Matsumoto; Yasuharu Tabara; Isuzu Nakamoto; Takuma Minami; Naomi Takahashi; Hirofumi Takeyama; Osamu Kanai; Satoshi Hamada; Kiminobu Tanizawa; Tomohiro Handa; Tomoko Wakamura; Naoko Komenami; Satoshi Morita; Takeo Nakayama; Toyohiro Hirai; Fumihiko Matsuda; Kazuo Chin
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.